{"schema_version":"secwatch.filing_event.v1","accession":"0001295947-26-000025","form_type":"8-K/A","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2026-06-30T10:01:12+00:00","discovered_at":"2026-06-30T10:10:00.320583+00:00","generated_at":"2026-06-30T10:10:58.086967+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Acquired OTC Wellness Business Q1 net sales $51.7M, net income $12.6M","bullets":["Net sales of $51.7M for Q1 2026, up 2.4% from $50.5M in Q1 2025.","Net income of $12.6M, down 14.4% from $14.8M in prior-year quarter.","Intangible assets net of $328.3M and goodwill of $151.5M as of March 31, 2026.","Business includes brands Breathe Right, Dimetapp, Anbesol, Alavert, Primatene, and others.","Pro forma financials for Prestige Consumer Healthcare also filed as part of the acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0001295947-26-000025","json":"https://secwatch.observer/filing/0001295947-26-000025.json","markdown":"https://secwatch.observer/filing/0001295947-26-000025.md","text":"https://secwatch.observer/filing/0001295947-26-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000129594726000025/0001295947-26-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000129594726000025/pbh-20260612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T10:10:58.086967+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}